Follow Us On

Facebook  X  Linkedin  YouTube
 
 

What do the proposed 2027 Physician and ASC Fee Schedules mean for your practice?

CMS has released its proposed Medicare Physician and Ambulatory Surgery Center (ASC) Fee Schedules, with changes that could significantly affect interventional pain physicians and ASCs.


For an overview of the proposal, read ASIPP's 2027 Proposed Medicare Fee Schedule: Another Cut for Interventional Pain, then join us for this complimentary webinar to hear our faculty discuss the proposed changes, their potential impact, and how physicians can effectively respond during the public comment period."


Click here to view the full schedule.


Click here to register.

 

ASIPP has submitted a proposal to the Centers for Medicare & Medicaid Services (CMS) proposing the creation of an Independent Physician Payment Modifier under Medicare.


The proposal is intended to help preserve independent physician practices by establishing a modifier that would identify qualifying independent physicians and provide a 10% payment adjustment for eligible physician services, while maintaining budget neutrality and protecting existing facility payments.


Click here to view ASIPP’s Letter to Joseph Albanese, CMS/CM


Click here to view ASIPP’s Proposed Modifier for Independent Physician Services

 

Ready to build your practical skills?


Join ASIPP in Memphis on August 28–29 for hands-on workshops in Ultrasound for Regenerative Medicine, Regenerative Medicine, and Interventional Techniques in IPM.


Also offering a $200 PNS workshop and a $100 introduction to the VIA Disc NP procedure.


Space is limited for these workshops. Early registration is encouraged.


Click here to learn more.

WORKSHOP ACCOMMODATIONS

Special room rate discount ends Thursday, August 13.

Click here to reserve your room TODAY!*

The Westin Memphis, Beale Street

170 Lt. George W Lee Ave, Memphis, TN 38103

901-334-5900


Click Here to Reserve Your Room*

*To receive the discounted room block rate of $189 plus tax per night let the hotel know you are with the ASIPP workshops.

Thank you to everyone who joined our highly

successful Peripheral Nerve Stimulation webinar!


Click here to watch the webinar recording.


We invite you to continue your educational experience

by joining us at the $200 PNS Hands-On Workshop.

FRIDAY, AUGUST 28



Ultrasound for Regenerative Medicine Hands-On Workshop



Earn 8 CMEs while gaining practical ultrasound experience focused on regenerative medicine applications.


Interested in intradiscal therapy?


Click here to watch the recording of ASIPP's Current Advances in Intradiscal Therapy webinar to explore expert insights.

Then join us in Memphis on Saturday, August 29 for an Introduction to the VIA Disc Nucleus Pulposus Allograft Procedure for $100.

Interested in advancing your knowledge of REGENERATIVE MEDICINE?


Watch the recording of ASIPP's complimentary webinar,

Current Advances and Future Directions of Regenerative Medicine,

to explore the topics and insights you can receive during our Hands-On Workshop.


Click here to watch the webinar recording.


Then take the next step and join us in

Memphis on August 29 for expert, hands-on instruction.

SATURDAY, AUGUST 29



Regenerative Medicine Hands-On Cadaver Workshop

(Basic, Intermediate, & Advanced)



Earn 8 CMEs in this cadaver workshop with hands-on instruction covering regenerative medicine techniques across varying experience levels.

SATURDAY, AUGUST 29



Interventional Techniques in IPM Hands-On Cadaver Workshop

(Basic, Intermediate & PNS)


Earn 8 CMEs in this workshop focused on interventional pain management techniques and peripheral nerve stimulation applications.

Medicare Improperly Paid Physicians an Estimated $15.2 Million for Sacroiliac Joint Injections 



This nationwide audit was conducted to determine whether Medicare paid physicians for sacroiliac joint injections in accordance with Medicare requirements and guidance. OIG found that of the 100 sampled sessions, 72 did not comply with Medicare requirements.


In addition, of the 100 sampled sessions, physicians’ billing for 25 sessions did not meet Medicare guidance. Based on OIG sample results, it is estimated that Medicare improperly paid $15.2 million for 134,526 of 186,842 total sessions from October 1, 2023, through September 30, 2024.

 

Why OIG Did This Audit

  • Sacroiliac joint injections (a type of spinal pain management service) are covered under Medicare Part B when medically reasonable and necessary.


  • In two prior audits of facet-joint interventions (another type of spinal pain management service), OIG found that Medicare paid for more than 50 percent of the sampled services that did not comply with one or more Medicare requirements.


  • Because OIG identified a high risk of noncompliance with facet-joint interventions, they conducted this nationwide audit to determine whether Medicare paid physicians for sacroiliac joint injections in accordance with Medicare requirements and guidance.


Click here to read the full report.

CMS has released the CY 2027 Medicare Physician Fee Schedule Proposed Rule (CMS-1848-P). The overall picture is unfavorable: CMS estimates a combined -2% impact on interventional pain management, with additional proposals affecting E/M billing, MIPS, and imaging/laboratory payment. Two documents are attached — the proposed rule and ASIPP’s code-by-code payment comparison for 2027 vs. 2026. Key points below.

 

Conversion Factor: Proposed Cut

With the one-year 2.5% statutory increase for 2026 expiring, CMS proposes:

  • Qualifying APM participants: $33.17, down from $33.57 (-1.19%)
  • All other clinicians (non-QP): $32.84, down from $33.40 (-1.68%)

These figures reflect a +0.53% budget-neutrality adjustment and statutory updates of +0.75% (QP) and +0.25% (non-QP). They do not include the 2% sequester or potential 4% PAYGO cuts.

 

IPM Codes: Widespread Reductions vs. 2026

Most interventional pain codes are cut 1–6% in the office setting and 1-4% in Facility:

Office Setting

Facility Setting

Epidurals

(62321 & 62323)

-3.0% to -3.3%

-2.7% to -3.0%

Transforaminal

(64479 to 64484)

-3.7% to -4.9%

-1.2% to -3.8%

Facet joint

(64490-64495)

-1.3% to -3.5%

-1.2% to -3.6%

Radiofrequency Ablation (64633-36)

-4.9% to -5.2%

-1.2% to -3.3%

SCS Lead Placement (63650)

-5.9%

-3.0%

EM Services

(99203-205, 213-215)

1.4% to -3.8%

-1.2% to -2.5%

  • Trigeminal nerve injection (64400): -19.9%; greater occipital nerve (64405): -16.6%
  • Percutaneous SI joint fusion (27279, facility): -14.9%
  • Kyphoplasty (22513–22515): -6.0% to -6.1%
  • Spinal cord stimulator trial (63650): -5.9%; percutaneous
  • PNS (64555): -6.3%


A handful of codes see small increases (e.g., blood patch 62273, several peripheral nerve blocks). The attached table shows every IPM code.


E/M Services: Major Change to Modifier -25

CMS proposes that when a separately identifiable office E/M visit is billed with modifier -25 on the same day as a 0-, 10-, or 90-day global procedure, only the highest-paid service is paid at 100% — all others, including the E/M visit, are cut 50%. This directly targets the common office-based scenario of a same-day evaluation and injection. CMS also proposes replacing add-on code G2211 with modifier MOD1, valued at 16% of the base E/M code (32% for ACO participants via MOD2). E/M payment rates themselves decline modestly (see attached table).


MIPS / Quality Payment Program

  • Traditional MIPS would sunset with the CY 2029 performance period (2031 payment year), making MIPS Value Pathways (MVPs) the sole reporting option; three new MVPs are proposed.
  • The quality measure inventory would be set at 180 measures (20 removals, 10 additions), with a new MIPS core measure reporting requirement replacing the outcome/high-priority measure requirement (small practices exempt).
  • The performance threshold remains 75 points. Separately, the rule proposes refinements to the Ambulatory Specialty Model (ASM), the mandatory model whose low back pain cohort includes interventional pain physicians.


RFI: Duplicate Laboratory Testing, Imaging, and Interoperability

CMS is seeking input on mechanisms to address duplicate laboratory and imaging tests, including MAC edits resulting in non-payment or reduced payment, recoupment of payments, frequency limitations, and revised billing instructions, along with improved result sharing and interoperability. These policies could significantly affect pain practices that rely on imaging and drug testing. ASIPP will submit detailed comments — please send us your input.


Act Now

Comments are due September 14, 2026 (file code CMS-1848-P). Please review the attached documents and send your feedback to asipp@asipp.org so we can represent you forcefully. ASIPP will fight these cuts, as we always have — but your voice makes the difference.


View the CY 2027 PFS Proposed Rule Fact Sheet


View the ASIPP 2027 vs. 2026 Proposed Payment Rate Comparison for IPM Codes

 

SAVE THE DATE - APRIL 15-17, 2027

Save the date for the American Society of Interventional Pain Physicians' 29th Annual Meeting, April 15 - 17, 2027, in Orlando, Florida.


This flagship educational event will bring together physicians, researchers, and healthcare professionals from across the country for three days of cutting-edge education, collaboration, and professional networking.


Attendees can look forward to our most comprehensive Annual Meeting yet, featuring new educational topics, expanded faculty participation, and innovative program enhancements designed to keep you at the forefront of interventional pain management.


Mark your calendar now and plan to join us in Orlando as we continue advancing excellence in interventional pain management. Additional program details and faculty announcements will be released soon.


Register by October 1, 2026, to receive a 10% Early Bird Discount.

Manufacturers Report $2.6 Billion in Open Payments to Physicians, but Product Details Remain Murky



Drug and medical device makers reported approximately $2.6 billion in payments to more than 665,000 physicians through the Open Payments program in 2025, according to a new analysis of federal data. 


The manufacturers paid an additional $1.3 billion to teaching hospitals and nonphysician practitioners, bringing total spending to about $3.9 billion, an 18.4% increase from the previous year.


The analysis was conducted by MedScout, an Austin, Texas-based healthcare data analytics company. The company recently published the findings on a searchable platform that allows users to examine Open Payments data by provider, company, product, and year-over-year changes since 2022.


Click here to read the full article.

ASIPP is proud to launch our Resident and Fellow Mentorship Program. This initiative is designed to connect trainees with experienced pain physicians to foster professional growth, provide guidance, and strengthen the future of our specialty.


Each mentor would be paired with one to two trainees, but can take more if interested. Trainees will be responsible for initiating introductions and arranging at least one to two video calls per year. These sessions will provide opportunities for mentees to seek advice on clinical decision-making, career planning, research opportunities, and professional development.


We believe that your experience, expertise, and insight can have a lasting impact on the next generation of pain physicians. By volunteering as a mentor, you will play a critical role in shaping the future of our field and ensuring that ASIPP continues to cultivate excellence in interventional pain medicine.


If you are interested in serving as a mentor, please confirm your participation by filling out the appropriate form below.


When Doctors Become Influencers: Where Social Media Crosses the Professional Line 



“Treat yourself to better vision for Christmas.” -- That was how a French ophthalmologist promoted his services online, alongside an offer of a free preoperative consultation. He was the majority shareholder of the aesthetic center where he worked. That promotion was penalized by the country’s national disciplinary chamber back in 2012.


Another physician was penalized in 2015 for receiving a share of subscription revenue from a website offering personalized nutritional advice under his supervision.


The cases predate France’s latest guidance for doctors posting online, but they capture the problem it is intended to address: where does professional communication end and inappropriate promotion or advice begin?


Click here to read the full article.

ASIPP is pleased to announce the launch of the Regenerative and Longevity Medicine Section!


This section reflects the growing importance of regenerative and longevity medicine—fields dedicated to restoring health, enhancing vitality, and extending the healthy years of life. From stem cell therapies and tissue engineering to gene therapy and orthobiologics, these disciplines are transforming the way we approach pain management and age-related decline.


Section membership offers:

  • Access to ASIPP’s physician database and future data registry
  • Opportunities for certification and continuing education
  • Section-exclusive resources and updates


No additional cost for ASIPP members!

CDC Warns of Severe Arboviral Disease With B-Cell Drugs 

Cases have included chronic, neurodegenerative encephalitis that played out over months to years



The CDC on Tuesday warned doctors about the risk for severe arboviral neuroinvasive disease in patients on B cell-depleting or modulating agents, calling out anti-CD20 monoclonal antibodies in particular.


Published case reports indicate an overall mortality of about 40% for patients on anti-CD20 antibodies with arboviral neuroinvasive disease, and neurologic sequelae were common in survivors. The most common virus involved in the reports was West Nile, but severe cases also involved eastern equine encephalitis, Powassan, La Crosse, and others.


"In recent years, a novel clinical presentation of chronic, neurodegenerative encephalitis developing over months to years has been described in at least five patients receiving rituximab who were infected with an orthobunyavirus, including Jamestown Canyon virus, Cache Valley virus, or Potosi virus," the CDC said in a Health Alert Network advisory.


Click here to read the full article.


Apply now for one of the following 2026 dates:



August 28, 2026


  • ABIPP Part II Oral and Practical Examination

Topics that will be covered:

Caudal epidural injections; Lumbar interlaminar epidural injections; Lumbar/sacral transforaminal epidural injections; Cervical epidural injections; Thoracic epidural injections; Lumbar/sacral medial branch and L5 dorsal ramus blocks; Cervical medial branch blocks; Thoracic medial branch blocks; Lumbar/sacral facet joint nerve radiofrequency neurolysis; Cervical medial branch radiofrequency neurolysis; Thoracic medial branch radiofrequency neurolysis; Sacroiliac joint injections; Cervical sympathetic blocks; Lumbar paravertebral sympathetic blocks; Intercostal nerve blocks; Lumbar discography; Celiac plexus blocks (not Splancnic nerve blocks); Percutaneous epidural adhesiolysis; Spinal cord stimulation lead placement



September 26, October 24, November 14,& December 12



  • ABIPP Part I

Four (4) hour virtual exam


  • ABIPP Path – Combined CCPM/ CSM Exam

For those with subspecialty in Pain Medicine

Two (2) hour virtual exam


  • ABIPP Competency Exam in IPM

For those without primary board certification

Two (2) hour virtual exam


  • ABIPP Competency Exam in Regenerative Medicine

Two (2) hour virtual exam


  • Controlled Substance Management Competency Exam

Two (2) hour virtual exam


  • Documentation, Coding, Compliance, Practice Management Competency Exam

Two (2) hour virtual exam

Exam Dates

Our Sponsor

Our Sponsor

Pain Medicine Case Reports (PMCR) and Editor-in-Chief Alaa Abd-Elsayed, MD, PhD would like to invite you to submit case reports and case series to the PMCR journal. Your article will be published free of charge.


Open access journals are freely available online for immediate worldwide open access to the full text of published articles. There is no subscription fee for open access journals. Open access journals are no different from traditional subscription-based journals: they undergo the same peer review and quality control as any other scholarly journal.


Interested in becoming a member of the PMCR Editorial Board?

Editorial board members are asked to review 2-6 manuscripts per year. Please submit your most up-to-date CV to sgold@asipp.org for consideration.


For more information or to submit your articles, click here.

We are excited to announce that Pain Medicine Case Reports (PMCR) journal (eISSN 2768-5152) has been accepted for inclusion in MEDLINE and PubMed, the prestigious bibliographic database of the U.S. National Library of Medicine. PMCR, a companion publication to the prestigious Pain Physician journal by ASIPP, joins its counterpart in achieving indexing in both MEDLINE and PubMed, marking ASIPP’s dual presence in these renowned databases.


The inclusion of PMCR journal in MEDLINE signifies a higher level of selectivity, as MEDLINE consists of the top 5,200 biomedical journals. This indexing also means that articles from PMCR will be searchable using NLM Medical Subject Headings (MeSH terms) and other metadata.


The selection for MEDLINE follows a rigorous evaluation process by reviewers from the Literature Selection Technical Review Committee (LSTRC). According to their criteria, the scientific quality of a journal’s content is the primary factor considered for indexing.


We extend our congratulations to the Pain Medicine Case Reports Editor-in-Chief, Deputy Editor-in-Chief, Journal Team, and Editorial Board for this achievement, which underscores the significance and excellence of this esteemed journal.

 

CASE REPORTS

Integrating Pain Management in a Patient With Cystic Fibrosis and Fibromyalgia: A Case Report


Persefoni Kritikou, PhD, Nikoletta Koffa, BS, Ioanna Loukou, PhD, and Athina Vadalouca, PhD

Statin-Associated Myopathy Mimicking Lumbar Radiculopathy: A Case Series


Ruben Dovlatyan, DO, Blake Jones, DO, Bruno Alonso, MD, Sidharth Sahni, DO, DPT, David Jevotovsky, MD, Dylan Banks, MD, Neal Rakesh, MD, and Richard Lau, MD

Platelet-Rich Plasma as Long-Term Therapy for Refractory Pain in an Atypical Case of Morton’s Neuroma: A Case Report


Muhamad Rafigi Hehsan, MBBCh, MMed

 

New Issue Now Available!

 
 

POPULATION-BASED STUDY

Chronic Pain-Associated Mortality in the United States: A Population-Based Study, 1999-2023


Ali Al-Salahat, MBChB, Mittal Prajapati, MD, Ali Bin Abdul Jabbar, MBBS, Jyotsna Nagda, MD, Peter S. Staats, MD, and Laxmaiah Manchikanti, MD

SYSTEMATIC REVIEWS

Comparative Efficacy of Dexmedetomidine and Esketamine on Postoperative Sleep Disturbances and Analgesia: A Systematic Review and Network Meta-Analysis


Ting Jiang, Rui Zhao, Yingli Zhang, Rui Zhang, Xiuqing Wu, Lina Jin, Yukun Huang, Yiwei Zhang, Wojciech Czyzewski, Grzegorz Staskiewicz, Karol Pruszynski, Changshun Huang, and Binbin Zhu

Safety and Effectiveness of Different Approaches for Epidural Steroid Injections in Lumbar Spinal Stenosis: A Systematic Review and Meta-Analysis


Igor Wilderman, Francesca Sarzetto, Tina Didari, Rotem Frish Manor, and Seyed Kourosh Ghavami Riabi




ASIPP is in collaboration with Curi Medical Liability Program




Since this malpractice insurance program officially launched in November 2018, ASIPP has signed up hundreds of providers with an average savings of 30%. This is professional liability insurance tailored to our specialty and will stand up for us and defend our practices. 

 

Curi is a full-service advisory firm that serves physicians and their practices. Their valued advice is grounded in your priorities and elevated in your outcomes. They are driven by a deep understanding of your specific circumstances in medicine, business, and life. To read a few important points to keep in mind about the program, including discounts, administrative defense, cyber coverage, aggressive claims handling, and complimentary risk management CME activities, visit our website.



IMPORTANT UPDATE

SPRINT no longer classified as PNT 



SPR is happy to announce an important update regarding Humana Medicare Advantage. As of May 1, Humana is now recognizing SPRINT as a PNS therapy. Previously, SPRINT was categorized as PNT (Percutaneous Nerve Stimulation), which allowed denials on the grounds that the therapy fell outside the NCD.


Additional details are as follows:

Payer: Humana Medicare Advantage (click here to view policy)

Policy Title: Peripheral Nerve Stimulators

Policy changes: SPRINT no longer misclassified as PNT and is now appropriately classified as PNS. Humana is applying the Noridian Medicare LCD criteria to ALL PNS devices – Including SPRINT PNS!

Effective Date: 5/1/2025


Click here to view a PDF of the official policy update.

 

Group Purchasing Organization Offer Better Pricing and Creates Added Value


ASIPP has formed a partnership with Henry Schein and PedsPal, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value-added services for independent physicians. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today.



Learn More


For updated information concerning tariffs on products, click here.

 
 

ASIPP, Fedora Healthcare Solutions Partnership


ASIPP offers our members the benefit of a unique revenue cycle management/ billing service.



We have received a tremendous amount of interest in the ASIPP billing and coding program.




Click here to learn more about the negotiated rate for practices and more!

Like and Follow ASIPP® on Facebook, X, LinkedIn,

and YouTube for the most up-to-date news

related to you, your practice, and your patients!